The Natural Metabolite 4-Cresol Improves Glucose Homeostasis and Enhances β-Cell Function

Archive ouverte

Brial, Francois | Alzaid, Fawaz | Sonomura, Kazuhiro | Kamatani, Yoichiro | Meneyrol, Kelly | Le Lay, Aurelie | Péan, Noémie | Hedjazi, Lyamine | Sato, Taka-Aki | Venteclef, Nicolas | Magnan, Christophe | Lathrop, Mark | Dumas, Marc-Emmanuel | Matsuda, Fumihiko | Zalloua, Pierre | Gauguier, Dominique

Edité par CCSD ; Elsevier Inc -

International audience. Exposure to natural metabolites contributes to the risk of cardiometabolic diseases (CMDs). Through metabolome profiling, we identify the inverse correlation between serum concentrations of 4-cresol and type 2 diabetes. The chronic administration of non-toxic doses of 4-cresol in complementary preclinical models of CMD reduces adiposity, glucose intolerance, and liver triglycerides, enhances insulin secretion in vivo, stimulates islet density and size, and pancreatic β-cell proliferation, and increases vascularization, suggesting activated islet enlargement. In vivo insulin sensitivity is not affected by 4-cresol. The incubation of mouse isolated islets with 4-cresol results in enhanced insulin secretion, insulin content, and β-cell proliferation of a magnitude similar to that induced by GLP-1. In both CMD models and isolated islets, 4-cresol is associated with the downregulated expression of the kinase DYRK1A, which may mediate its biological effects. Our findings identify 4-cresol as an effective regulator of β-cell function, which opens up perspectives for therapeutic applications in syndromes of insulin deficiency.

Suggestions

Du même auteur

Dominant gut Prevotella copri in gastrectomised non-obese diabetic Goto–Kakizaki rats improves glucose homeostasis through enhanced FXR signalling

Archive ouverte | Péan, Noémie | CCSD

International audience. Aims/hypothesisDrug and surgical-based therapies in type 2 diabetes are associated with altered gut microbiota architecture. Here we investigated the role of the gut microbiome in improved gl...

Systems Genetics of Hepatic Metabolome Reveals Octopamine as a Target for Non-Alcoholic Fatty Liver Disease Treatment

Archive ouverte | Brial, Francois | CCSD

International audience. Non-alcoholic fatty liver disease (NAFLD) is often associated with obesity and type 2 diabetes. To disentangle etiological relationships between these conditions and identify genetically-dete...

Untargeted Mass Spectrometry Lipidomics identifies correlation between serum sphingomyelins and plasma cholesterol

Archive ouverte | Zalloua, Pierre | CCSD

International audience. BACKGROUND: Lipoproteins are major players in the development and progression of atherosclerotic plaques leading to coronary stenosis and myocardial infarction. Epidemiological, genetic and e...

Chargement des enrichissements...